The Non-Vascular Stents Market Is Predicted To Reach USD 1.2 Billion With A CAGR Of 5.5% According To Market Data Forecast Report.

The Non-Vascular Stents Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Non-Vascular Stents Market is estimated to be USD 920 million in 2017 and predicted to rise to USD 1.2 billion by 2022 with a CAGR of 5.5%. The market is segmented by End User (Hospitals, Ambulatory Surgical Centers, Others), by Material (Metallic Stents, Non-metallic Stents), by Type (Pancreatic and Biliary Stents, Gastrointestinal Stents, Airway Stents, Urinary Tract Stents). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.

Stents are the tubes or other devices that placed in the body to generate a passage between hollow spaces. And stenting is process of placement of such stent in the body. Non-vascular stents are usually utilized for making a pathway in vessels of the body particularly the arteries and veins that carry lymph and blood.

Rapid technological advancements in the healthcare sector, increasing disease prevalence of cancer and urolithiasis, augmenting geriatric population and increased life expectancy are the primary drivers of market growth.

However, stringent administrative framework, unreliable efficiency, pricing pressures, and medical devices excise taxes are the primary restraints of this market.

By geography the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. North America held over 32.0% share in the market in 2016 owing to increasing prevalence of lung cancer, glaucoma, central airway obstruction, COPD, asthma, and other chronic diseases in the U.S. and Canada. Local presence of major market players, target population, and robust healthcare infrastructure in the region further supported the dominance of this region. Europe is also expected to hold a substantial market share during the forecast period due to the flourishing medical technology sector and increasing prevalence of gastric cancer in the EU5 countries. On the other hand, Asia Pacific is expected to register higher CAGR over the forecast period as compared to other regions due to favorable government initiatives for use of such medical devices, rising geriatric population, and increasing healthcare expenditure.